Cipher Pharmaceuticals Inc. (TSE:CPH – Get Free Report) (NASDAQ:CPHR) shares crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$15.43 and traded as low as C$14.48. Cipher Pharmaceuticals shares last traded at C$14.74, with a volume of 15,841 shares.
Cipher Pharmaceuticals Stock Performance
The company has a market cap of C$374.31 million, a P/E ratio of 32.04 and a beta of 0.77. The firm has a 50 day moving average price of C$15.43 and a 200-day moving average price of C$13.89. The company has a debt-to-equity ratio of 41.22, a quick ratio of 2.67 and a current ratio of 2.00.
Cipher Pharmaceuticals Company Profile
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company’s geographical segments include Canada and the United States.
Featured Articles
- Five stocks we like better than Cipher Pharmaceuticals
- Technology Stocks Explained: Here’s What to Know About Tech
- Semiconductor Supercycle: Why Onsemi Stock Could Double as AI and EV Growth Accelerate
- Best Stocks Under $5.00
- The Best Local Butchers for Thanksgiving [2025 Survey]
- Which Wall Street Analysts are the Most Accurate?
- $134M in Insider Moves: What It Might Mean for KMI, ISRG and QS
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
